Skip to content

Smallest Significant Value in Osteodensitomery in an Obese Population

Smallest Significant Value in Osteodensitomery in an Obese Population

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04301427
Acronym
PPVS-ob
Enrollment
120
Registered
2020-03-10
Start date
2019-11-15
Completion date
2020-08-31
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Bone density, Osteoporosis, Osteopenia, Obesity, OSteodensitometry

Brief summary

The aim of this study is to determined the smallest significant value in osteodensitometry in obese population. The study population will be divided in 3 groups according to their BMI. Bone mineral density will be measured twice in osteodensitometry, then the smallest significant value will be determined. Our hypothesis is that the smallest significant value that we use in an non-obese population can be different in an obese population.

Detailed description

The aim of this study is to determined the smallest significant value in osteodensitometry in obese population. There will be at least 120 patient included. The study population will be divided in 3 groups according to their BMI : the first group has a BMI between 30 and 35 kg/cm² ; the second group has a BMI between 35 et 40 kg/cm² ; and the third group has a BMI over 40 kg/cm². Patients will be referred by their doctors (rheumatologist and others) to evaluate their bone mineral density in osteodensitometry at CHU of Reims. Patients will be informed of the aim of the study by the prescriptor of the osteodensitometry. The osteodensitometry will be executed by a nurse. Patients will have to complete a questionnaire about their medical history and their medications. Bone mineral density will be measured twice in osteodensitometry, at the lumbar spine, the hip and the femur. This exam lasts approximately 40 minutes. Then the smallest significant value will be determined by comparing each measure for every patients.

Interventions

OTHERBone mineral density

Bone mineral density will be measured twice in all included patients.

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: * Major patients * Patients referred to the CHU of Reims to make an osteodensitometric evaluation of their bone mineral density * BMI \> 30 kg/cm² * Patient affiliated to a health insurance plan * Patients who have signed informed consent

Exclusion criteria

: * Minor patients * Pregnant women * Patients protected by the law

Design outcomes

Primary

MeasureTime frameDescription
osteodensitometry in obese populationDay 1smallest significant value in osteodensitometry in obese population

Secondary

MeasureTime frameDescription
osteodensitometry in obese population with BMI between 30 and 35 kg/cm²Day 1smallest significant value in osteodensitometry in obese population with BMI between 30 et 35 kg/cm²
osteodensitometry in obese population with BMI between 35 and 40 kg/cm²Day 1smallest significant value in osteodensitometry in obese population with BMI between 35 et 40 kg/cm²
osteodensitometry in obese population with BMI over 40 kg/cm²Day 1Smallest significant value in osteodensitometry in obese population with BMI over 40 kg/cm²

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026